Statement re DXS Secures Innovate UK grant

DXS International

30/11/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231130:nGNEDVbKy&default-theme=true


DXS INTERNATIONAL PLC

DXS Secures Innovate UK grant to advance 
its precision medicines AI solution

The Board of DXS International plc (the “Company”), the AQSE Growth Market
quoted clinical decision support developer and supplier of clinical decision
support systems is pleased to announce its success in securing £409,000 of
grant funding jointly with Health Innovation East from Innovate UK – the
UK’s national innovation agency - for further research and development of
its Artificial Intelligence medicines optimisation prescribing solution,
ExpertCare.

The Innovate UK grant will enable DXS to accelerate its efforts in advancing
ExpertCare, a product promising to revolutionise medicine optimisation. The
funds channelled into intensive research, prototyping, and testing will pave
the way for ExpertCare’s ongoing development and route to market.

The Innovate UK, DXS and Health Innovation East research and development
project (funded for 18- months) will consist of two primary elements:
* A comprehensive cost-to-benefit analysis in the form of a real-world
evaluation led by the Health Innovation East to evaluate ExpertCare's utility
within a clinical environment. The evaluation will include an analysis of user
experience and patient/public engagement.
* The second element of the project is the development and prototyping of two
additional cardiovascular related long-term condition AI algorithms, namely
diabetes and hypercholesterolemia, together with common relevant
comorbidities.
The Innovate UK grant comes on the back of a 2022 National Institute of Health
and Care Research (“NIHR”) grant award for an initial first stage
ExpertCare real world evidence evaluation, the results of which are soon to be
published.

David Immelman, DXS’s CEO commented: “The Innovate UK grant award is
crucial step forward for DXS. Not only do they confirm health industry
recognition of the innovativeness of ExpertCare, but also the need for digital
health solutions that address real problems confronted by the UK National
Health Service (“NHS”).

We are delighted to be working with Innovate UK, the UK’s innovation agency
which funds business and research collaborations to accelerate innovation and
drive business investment into research and development. The organisation is
renowned for its mission to drive innovation and growth in the UK’s most
promising sectors. For more information visit
www.ukri.org/councils/innovate-uk/ .

DXS is also pleased to be working with Health Innovation East, one of 15 UK
Academic Health Sciences Networks (“AHSNs”) that connect NHS and academic
organisations, local authorities, charities, and industry and provide a range
of practical support to facilitate change across health and social care
economies, with a clear focus on improving outcomes for patients.

AHSNs are uniquely placed to identify and spread health innovation at pace and
scale; driving the adoption and spread of innovative ideas and technologies
across large populations. For more information visit
www.healthinnovationeast.co.uk/ “.

The Directors of DXS International plc accept responsibility for this
announcement

Enquiries:

 David Immelman (Chief Executive) DXS International plc      01252 719800 david@dxs-systems.com  
 Wrecclesham House Wrecclesham Road Farnham Surrey GU10 4PS                                      
 www.dxs-systems.co.uk                                                                           



 Corporate Advisor                              
 City & Merchant David Papworth  0207 101 7676  



 Corporate Broker                                 
 Hybridan LLP Claire Louise Noyce  020 3764 2341  

Note to Editors:

DXS International presents up to date treatment guidelines and
recommendations, from Clinical Commissioning Groups and other trusted NHS
sources, to doctors, nurses and pharmacists in their workflow and during the
patient consultation. This effective clinical decision support ultimately
translates to improved healthcare outcomes delivered more cost effectively
which should significantly contribute towards the NHS achieving its projected
efficiency savings